{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:10:31Z","timestamp":1788739831962,"version":"build-2803163510"},"update-to":[{"DOI":"10.1002\/14651858.cd010189.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000}}],"reference-count":105,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010189.pub3","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T06:31:28Z","timestamp":1730961088000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults"],"prefix":"10.1002","volume":"2024","author":[{"given":"Sinje","family":"Kiene","sequence":"additional","affiliation":[{"name":"Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Stem Cell Transplantation Program, Faculty of Medicine and University Hospital Cologne; University of Cologne; Cologne Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Albrecht","sequence":"additional","affiliation":[{"name":"Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Stem Cell Transplantation Program, Faculty of Medicine and University Hospital Cologne; University of Cologne; Cologne Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Theurich","sequence":"additional","affiliation":[{"name":"Department of Medicine III; University Hospital LMU, Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen; Munich Germany"},{"name":"Cancer- and Immunometabolism Research Group; Gene Center LMU, Munich; Munich Germany"},{"name":"German Cancer Consortium (DKTK), Munich Site; German Cancer Research Center, Heidelberg, Germany.; Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christof","family":"Scheid","sequence":"additional","affiliation":[{"name":"Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Stem Cell Transplantation Program; Faculty of Medicine and University Hospital Cologne, University of Cologne; Cologne Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Skoetz","sequence":"additional","affiliation":[{"name":"Cochrane Evidence Synthesis Unit Germany, Institute of Public Health; Faculty of Medicine and University Hospital Cologne, University of Cologne; Cologne Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"Holtick","sequence":"additional","affiliation":[{"name":"Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Stem Cell Transplantation Program, Faculty of Medicine and University Hospital Cologne; University of Cologne; Cologne Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,11,7]]},"reference":[{"issue":"16","key":"10.1002\/14651858.CD010189.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJMoa1203517","article-title":"Peripheral-blood stem cells versus bone marrow from unrelated donors","volume":"367","author":"Anasetti","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"12","key":"10.1002\/14651858.CD010189.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1001\/jamaoncol.2016.2520","article-title":"Comparison of patient-reported outcomes in 5-year survivors who received bone marrow vs peripheral blood unrelated donor transplantation: long-term follow-up of a randomized clinical trial","volume":"2","author":"Lee","year":"2016","journal-title":"JAMA Oncology"},{"issue":"2","key":"10.1002\/14651858.CD010189.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.bbmt.2015.09.013","article-title":"Infections following transplantation of bone marrow or peripheral-blood stem cells from unrelated donors","volume":"22","author":"Young","year":"2016","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD010189.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1182\/blood-2002-01-0048","article-title":"A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies","volume":"100","author":"Couban","year":"2002","journal-title":"Blood"},{"issue":"4","key":"10.1002\/14651858.CD010189.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1470-2045(09)70352-3","article-title":"Long-term outcome and late effects in patients transplanted with mobilised blood or bone marrow: a randomised trial","volume":"11","author":"Friedrichs","year":"2010","journal-title":"Lancet Oncology"},{"issue":"5","key":"10.1002\/14651858.CD010189.pub3-BIB0006|cit6","first-page":"643","article-title":"Filgrastim-mobilized peripheral blood progenitor cells versus bone marrow transplantation for treating leukemia: 3-year results from the EBMT randomized trial","volume":"90","author":"Schmitz","year":"2005","journal-title":"Haematologica"},{"issue":"3","key":"10.1002\/14651858.CD010189.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1182\/blood-2001-12-0304","article-title":"Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia","volume":"100","author":"Schmitz","year":"2002","journal-title":"Blood"},{"issue":"1","key":"10.1002\/14651858.CD010189.pub3-BIB0008|cit8","first-page":"86","article-title":"Immune reconstitution after allogeneic stem cell transplantation: the impact of stem cell source and graft-versus-host disease","volume":"90","author":"Abrahamson","year":"2005","journal-title":"Haematologica"},{"issue":"3","key":"10.1002\/14651858.CD010189.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/sj.bmt.1704127","article-title":"Fewer relapses and increased chronic GVHD in patients transplanted with blood stem cells: a 5-year follow-up in a single centre study","volume":"32","author":"Heldal","year":"2003","journal-title":"Bone Marrow Transplantation"},{"key":"10.1002\/14651858.CD010189.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/sj.bmt.1701906","article-title":"Peripheral blood vs bone marrow as a source for allogeneic hematopoietic stem cell transplantation","volume":"24","author":"Mahmoud","year":"1999","journal-title":"Bone Marrow Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD010189.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1056\/NEJM200101183440303","article-title":"Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers","volume":"344","author":"Bensinger","year":"2001","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD010189.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1182\/blood-2002-01-0011","article-title":"Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial","volume":"100","author":"Flowers","year":"2002","journal-title":"Blood"},{"key":"10.1002\/14651858.CD010189.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1182\/blood-2011-12-396275","article-title":"Long-term outcomes after transplantation of HLA-identical related G-CSF-mobilized peripheral blood mononuclear versus bone marrow","volume":"119","author":"Mielcarek","year":"2012","journal-title":"Blood"},{"issue":"2","key":"10.1002\/14651858.CD010189.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bbmt.2004.09.010","article-title":"Randomized trial of allogeneic related bone marrow transplantation versus peripheral blood stem cell transplantation for chronic myeloid leukemia","volume":"11","author":"Oehler","year":"2005","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD010189.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1200\/JCO.2000.18.3.537","article-title":"Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Soci\u00e9t\u00e9 Fran\u00e7aise de Greffe de Moelle","volume":"18","author":"Blaise","year":"2000","journal-title":"Journal of Clinical Oncology"},{"issue":"9","key":"10.1002\/14651858.CD010189.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1182\/blood.V100.9.3128","article-title":"Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study","volume":"100","author":"Mohty","year":"2002","journal-title":"Blood"},{"issue":"9211","key":"10.1002\/14651858.CD010189.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(00)02090-0","article-title":"Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial","volume":"355","author":"Powles","year":"2000","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD010189.pub3-BIB0018|cit18","first-page":"1281","article-title":"Quality of life in patients randomized to receive a bone marrow or a peripheral blood allograft","volume":"87","author":"De Souza","year":"2002","journal-title":"Haematologica"},{"issue":"4","key":"10.1002\/14651858.CD010189.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1399-3062.2003.00033.x","article-title":"Infectious complications in patients randomized to receive allogeneic bone marrow or peripheral blood transplantation","volume":"5","author":"Nucci","year":"2003","journal-title":"Transplant Infectious Disease"},{"issue":"12","key":"10.1002\/14651858.CD010189.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/sj.bmt.1701510","article-title":"A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignancies","volume":"22","author":"Vigorito","year":"1998","journal-title":"Bone Marrow Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD010189.pub3-BIB0021|cit21","first-page":"665","article-title":"A randomized, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of hematologic malignancies: an update","volume":"86","author":"Vigorito","year":"2001","journal-title":"Haematologica"},{"issue":"12","key":"10.1002\/14651858.CD010189.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1038\/s41409-022-01822-3","article-title":"Comparable survival outcomes with haploidentical stem cell transplantation and unrelated bone marrow transplantation","volume":"57","author":"Atsuta","year":"2022","journal-title":"Bone Marrow Transplantation"},{"issue":"8","key":"10.1002\/14651858.CD010189.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3324\/haematol.2011.054841","article-title":"Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups","volume":"97","author":"Bacigalupo","year":"2012","journal-title":"Haematologica"},{"issue":"26","key":"10.1002\/14651858.CD010189.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1200\/JCO.2017.72.8428","article-title":"Mobilized peripheral blood stem cells versus unstimulated bone marrow as a graft source for T-cell-replete haploidentical donor transplantation using post-transplant cyclophosphamide","volume":"35","author":"Bashey","year":"2017","journal-title":"Journal of Clinical Oncology"},{"issue":"9","key":"10.1002\/14651858.CD010189.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.bbmt.2015.06.006","article-title":"Influence of stem cell source on outcomes of allogeneic reduced-intensity conditioning therapy transplants using haploidentical related donors","volume":"21","author":"Bradstock","year":"2015","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"12","key":"10.1002\/14651858.CD010189.pub3-BIB0026|cit26","first-page":"3702","article-title":"Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT)","volume":"95","author":"Champlin","year":"2000","journal-title":"Blood"},{"issue":"10","key":"10.1002\/14651858.CD010189.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0301-472X(03)00195-4","article-title":"A randomized multicenter comparison of CD34(+)-selected progenitor cells from blood vs from bone marrow in recipients of HLA-identical allogeneic transplants for hematological malignancies","volume":"31","author":"Cornelissen","year":"2003","journal-title":"Experimental Hematology"},{"issue":"8","key":"10.1002\/14651858.CD010189.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.bbmt.2016.04.017","article-title":"Filgrastim-stimulated bone marrow compared with filgrastim-mobilized peripheral blood in myeloablative sibling allografting for patients with hematologic malignancies: a randomized Canadian blood and marrow transplant group study","volume":"22","author":"Couban","year":"2016","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD010189.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1200\/JCO.2014.57.2446","article-title":"Bone marrow or peripheral blood for reduced-intensity conditioning unrelated donor transplantation","volume":"33","author":"Eapen","year":"2015","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"10.1002\/14651858.CD010189.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13045-017-0503-2","article-title":"Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia","volume":"10","author":"Fan","year":"2017","journal-title":"Journal of Hematology & Oncology"},{"issue":"9","key":"10.1002\/14651858.CD010189.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/sj.bmt.1704245","article-title":"Differences between graft product and donor side effects following bone marrow or stem cell donation","volume":"32","author":"Favre","year":"2003","journal-title":"Bone Marrow Transplantation"},{"key":"10.1002\/14651858.CD010189.pub3-BIB0032|cit32","first-page":"2039","article-title":"Comparison of mobilized peripheral blood stem cells versus unmanipulated bone marrow haploidentical transplantation using post-transplant cyclophosphamide: a retrospective study of SFGM-TC in 176 patients","volume":"130","author":"Jacque","year":"2017","journal-title":"Blood"},{"issue":"10","key":"10.1002\/14651858.CD010189.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jcyt.2022.05.009","article-title":"Advantages of peripheral blood stem cells from unrelated donors versus bone marrow transplants in outcomes of adult acute myeloid leukemia patients","volume":"24","author":"Jo","year":"2022","journal-title":"Cytotherapy"},{"issue":"11","key":"10.1002\/14651858.CD010189.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1182\/blood.V104.11.3321.3321","article-title":"Peripheral blood stem cells vs bone marrow for matched sibling transplant in AML and ALL remission [abstract]","volume":"104","author":"Kirschbaum","year":"2012","journal-title":"Blood"},{"key":"10.1002\/14651858.CD010189.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.bbmt.2016.01.012","article-title":"Comparing outcomes with bone marrow or peripheral blood stem cells as graft source for matched sibling transplants in severe aplastic anemia across different economic regions","volume":"22","author":"Kumar","year":"2016","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1002\/14651858.CD010189.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"764","DOI":"10.3324\/haematol.2015.138990","article-title":"Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adults","volume":"101","author":"Mehta","year":"2016","journal-title":"Haematologica"},{"issue":"12","key":"10.1002\/14651858.CD010189.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1003.e1","DOI":"10.1016\/j.jtct.2021.09.003","article-title":"Bone marrow versus peripheral blood grafts for haploidentical hematopoietic cell transplantation with post-transplantation cyclophosphamide","volume":"27","author":"Mehta","year":"2021","journal-title":"Transplantation and Cellular Therapy"},{"issue":"12","key":"10.1002\/14651858.CD010189.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1182\/blood.V98.12.3186","article-title":"Granulocyte-colony-stimulating factor (G-CSF)-primed allogeneic bone marrow: significantly less graft-versus-host disease and comparable engraftment to G-CSF-mobilized peripheral blood stem cells","volume":"98","author":"Morton","year":"2001","journal-title":"Blood"},{"issue":"10","key":"10.1002\/14651858.CD010189.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1038\/s41375-020-0850-9","article-title":"Bone marrow versus mobilized peripheral blood stem cell graft in T-cell-replete haploidentical transplantation in acute lymphoblastic leukemia","volume":"34","author":"Nagler","year":"2020","journal-title":"Leukemia"},{"issue":"11","key":"10.1002\/14651858.CD010189.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.bbmt.2009.07.009","article-title":"Decision analysis of peripheral blood versus bone marrow hematopoietic stem cells for allogeneic hematopoietic cell transplantation","volume":"15","author":"Pidala","year":"2009","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD010189.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1473-0502(03)00104-6","article-title":"Blood versus marrow hematopoietic allogeneic graft","volume":"29","author":"Robinet","year":"2003","journal-title":"Transfusion and Apheresis Science"},{"issue":"13","key":"10.1002\/14651858.CD010189.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.3390\/jcm10132843","article-title":"Outcomes of bone marrow compared to peripheral blood for haploidentical transplantation","volume":"10","author":"Sharma","year":"2021","journal-title":"Journal of Clinical Medicine"},{"key":"10.1002\/14651858.CD010189.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/ejh.12287","article-title":"Similar outcomes of peripheral blood stem cells vs. bone marrow for human leukocyte antigen-matched unrelated donor transplantation in adult patients with acute myeloid leukemia using risk-adapted graft-versus-host disease prophylaxis","volume":"93","author":"Shin","year":"2014","journal-title":"European Journal of Haematology"},{"issue":"11","key":"10.1002\/14651858.CD010189.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1182\/blood.V97.11.3380","article-title":"Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation","volume":"97","author":"Storek","year":"2001","journal-title":"Blood"},{"issue":"1","key":"10.1002\/14651858.CD010189.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.bbmt.2013.10.024","article-title":"Health-related quality of life of bone marrow versus peripheral blood stem cell donors: a prespecified subgroup analysis from a Phase III RCT-BMTCTN Protocol 0201","volume":"20","author":"Switzer","year":"2014","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD010189.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.bbmt.2019.09.036","article-title":"Time-varying effects of graft type on outcomes for patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation","volume":"26","author":"Yanada","year":"2020","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD010189.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1056\/NEJM200101183440303","article-title":"Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers","volume":"344","author":"Bensinger","year":"2001","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD010189.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/CCO.0b013e32834f5c27","article-title":"Allogeneic transplantation: peripheral blood versus bone marrow","volume":"24","author":"Bensinger","year":"2012","journal-title":"Current Opinion in Oncology"},{"key":"10.1002\/14651858.CD010189.pub3-BIB0049|cit49","unstructured":"Bolon YT Atshan R Allbee-Johnson M Estrada-Merly N Lee SJ Current use and outcome of hematopoietic stem cell transplantation: CIBMTR summary slides, 2022 Available at www.cibmtr.org"},{"key":"10.1002\/14651858.CD010189.pub3-BIB0050|cit50","unstructured":"Boutron I Page MJ Higgins JP Altman DG Lundh A Hr\u00f3bjartsson A Chapter 7: Considering bias and conflicts of interest among the included studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook\/archive\/v6.3"},{"issue":"9","key":"10.1002\/14651858.CD010189.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.bbmt.2013.06.008","article-title":"Outcomes of patients age 70 or older undergoing allogeneic hematopoietic stem cell transplantation for hematologic malignancies","volume":"19","author":"Brunner","year":"2013","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD010189.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00277-011-1299-8","article-title":"Allogeneic bone marrow transplantation compared to peripheral blood stem cell transplantation for the treatment of hematologic malignancies: a meta-analysis based on time-to-event data from randomized controlled trials","volume":"91","author":"Chang","year":"2012","journal-title":"Annals of Hematology"},{"key":"10.1002\/14651858.CD010189.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2141.2007.06524.x","article-title":"Long-term safety of filgrastim (rhG-CSF) administration","volume":"137","author":"Confer","year":"2007","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD010189.pub3-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/9781444303537.ch38","volume-title":"Thomas' Hematopoietic Cell Transplantation","author":"Confer","year":"2009"},{"issue":"2","key":"10.1002\/14651858.CD010189.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1046\/j.1537-2995.2001.41020190.x","article-title":"CD34+ cell mobilization for allogeneic progenitor cell transplantation: efficacy of a short course of G-CSF","volume":"41","author":"Fabritiis","year":"2001","journal-title":"Transfusion"},{"issue":"12","key":"10.1002\/14651858.CD010189.pub3-BIB0056|cit56","first-page":"1281","article-title":"Quality of life in patients randomized to receive a bone marrow or a peripheral blood allograft","volume":"87","author":"De Souza","year":"2002","journal-title":"Haematologica"},{"key":"10.1002\/14651858.CD010189.pub3-BIB0057|cit57","unstructured":"Deeks JJ Higgins JP Altman DG Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook\/archive\/v6.3"},{"issue":"12","key":"10.1002\/14651858.CD010189.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.bbmt.2007.08.006","article-title":"Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival","volume":"13","author":"Eapen","year":"2007","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"9674","key":"10.1002\/14651858.CD010189.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0140-6736(09)60237-3","article-title":"Graft-versus-host disease","volume":"373","author":"Ferrara","year":"2009","journal-title":"Lancet"},{"issue":"12","key":"10.1002\/14651858.CD010189.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD010189.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"e293","DOI":"10.1016\/S2352-3026(17)30081-9","article-title":"Long-term outcomes after standard graft-versus-host disease prophylaxis with or without anti-human-T-lymphocyte immunoglobulin in haemopoietic cell transplantation from matched unrelated donors: final results of a randomised controlled trial","volume":"4","author":"Finke","year":"2017","journal-title":"Lancet Haematology"},{"issue":"5","key":"10.1002\/14651858.CD010189.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.coi.2006.07.014","article-title":"Donor selection for unrelated cord blood transplants","volume":"18","author":"Gluckman","year":"2006","journal-title":"Current Opinion in Immunology"},{"issue":"4","key":"10.1002\/14651858.CD010189.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors","volume":"18","author":"Glucksberg","year":"1974","journal-title":"Transplantation"},{"key":"10.1002\/14651858.CD010189.pub3-BIB0064|cit64","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime) 2023"},{"issue":"5","key":"10.1002\/14651858.CD010189.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"908","DOI":"10.3324\/haematol.2013.096461","article-title":"Use of the quality management system \"JACIE\" and outcome after hematopoietic stem cell transplantation","volume":"99","author":"Gratwohl","year":"2014","journal-title":"Haematologica"},{"key":"10.1002\/14651858.CD010189.pub3-BIB0066|cit66","unstructured":"Higgins JP Altman DG Sterne JAC Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1"},{"key":"10.1002\/14651858.CD010189.pub3-BIB0067|cit67","unstructured":"Higgins JP Li T Deeks JJ Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook\/archive\/v6.3"},{"issue":"4","key":"10.1002\/14651858.CD010189.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"217 e1","DOI":"10.1016\/j.jtct.2022.01.012","article-title":"Comparison of quality of life and outcomes between haploidentical and matched related\/unrelated donor allogeneic hematopoietic cell transplantation","volume":"28","author":"Hong","year":"2022","journal-title":"Transplantation and Cellular Therapy"},{"issue":"1","key":"10.1002\/14651858.CD010189.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.blre.2005.01.007","article-title":"Chronic graft-versus-host disease","volume":"20","author":"Horwitz","year":"2006","journal-title":"Blood Reviews"},{"issue":"3","key":"10.1002\/14651858.CD010189.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrc2804","article-title":"Allogeneic hematopoietic stem cell transplantation: individualized stem cell and immunotherapy of cancer","volume":"10","author":"Jenq","year":"2010","journal-title":"Nature Reviews of Cancer"},{"key":"10.1002\/14651858.CD010189.pub3-BIB0071|cit71","volume-title":"The Statistical Analysis of Failure Time Data","author":"Kalb\ufb02eisch","year":"1980"},{"issue":"7","key":"10.1002\/14651858.CD010189.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.bbmt.2020.03.002","article-title":"Indications for hematopoietic cell transplantation and immune effector cell therapy: guidelines from the american society for transplantation and cellular therapy","volume":"26","author":"Kanate","year":"2020","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1002\/14651858.CD010189.pub3-BIB0073|cit73","unstructured":"Labopin M Iacobelli S Statistical guidelines for EBMT www.researchgate.net\/publication\/228991700_Statistical_guidelines_for_EBMT"},{"key":"10.1002\/14651858.CD010189.pub3-BIB0074|cit74","unstructured":"Labopin M Latouche A Suciu S Santucci A Canals C Iacobelli S Definitions and evaluation of endpoints following stem cells transplantation - recommendation from the European group for Blood and Marrow transplantation (EBMT). CLINT, Work Package 5 2009 www.academia.edu\/107154526"},{"issue":"12","key":"10.1002\/14651858.CD010189.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1001\/jamaoncol.2016.2520","article-title":"Comparison of patient-reported outcomes in 5-year survivors who received bone marrow vs peripheral blood unrelated donor transplantation: long-term follow-up of a randomized clinical trial","volume":"2","author":"Lee","year":"2016","journal-title":"JAMA Oncology"},{"key":"10.1002\/14651858.CD010189.pub3-BIB0076|cit76","unstructured":"Lefebvre C Glanville J Briscoe S Featherstone R Littlewood A Marshall C Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook\/archive\/v6.3"},{"key":"10.1002\/14651858.CD010189.pub3-BIB0077|cit77","unstructured":"Li T Higgins JP Deeks JJ Chapter 5: Collecting data. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook\/archive\/v6.3"},{"issue":"6","key":"10.1002\/14651858.CD010189.pub3-BIB0078|cit78","first-page":"641","article-title":"HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide","volume":"14","author":"Luznik","year":"2008","journal-title":"Blood"},{"issue":"4","key":"10.1002\/14651858.CD010189.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1200\/JCO.21.02293","article-title":"Randomized Phase III BMT CTN trial of calcineurin inhibitor\u2013free chronic graft-versus-host disease interventions in myeloablative hematopoietic cell transplantation for hematologic malignancies","volume":"40","author":"Luznik","year":"2022","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD010189.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/978-3-030-02278-5_25","volume-title":"The EBMT handbook: hematopoietic stem cell transplantation and cellular therapies","author":"Michonneau","year":"2019"},{"issue":"10","key":"10.1002\/14651858.CD010189.pub3-BIB0081|cit81","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD015045","article-title":"Colchicine for the treatment of COVID-19","author":"Mikolajewska","year":"2021","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD010189.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"Journal of Clinical Epidemiology"},{"issue":"9","key":"10.1002\/14651858.CD010189.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.bbmt.2012.02.013","article-title":"Mobilized peripheral blood stem cells compared with bone marrow as the stem cell source for unrelated donor allogeneic transplantation with reduced-intensity conditioning in patients with acute myeloid leukemia in complete remission: an analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation","volume":"18","author":"Nagler","year":"2012","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"24","key":"10.1002\/14651858.CD010189.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Statistics in Medicine"},{"issue":"7","key":"10.1002\/14651858.CD010189.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1038\/s41409-021-01227-8","article-title":"Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years","volume":"56","author":"Passweg","year":"2021","journal-title":"Bone Marrow Transplantation"},{"issue":"25","key":"10.1002\/14651858.CD010189.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1056\/NEJMoa011826","article-title":"Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation","volume":"345","author":"Petersdorf","year":"2001","journal-title":"New England Journal of Medicine"},{"issue":"11","key":"10.1002\/14651858.CD010189.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.bbmt.2009.07.009","article-title":"Decision analysis of peripheral blood versus bone marrow hematopoietic stem cells for allogeneic hematopoietic cell transplantation","volume":"15","author":"Pidala","year":"2009","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD010189.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1097\/COC.0b013e31817f9de1","article-title":"Nonmyeloablative and reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation","volume":"32","author":"Pollack","year":"2009","journal-title":"American Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD010189.pub3-BIB0089|cit89","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2024"},{"issue":"5","key":"10.1002\/14651858.CD010189.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1365-2796.2012.02547.x","article-title":"Bone marrow or peripheral blood stem cell transplantation from unrelated donors in adult patients with acute myeloid leukaemia, an Acute Leukaemia Working Party analysis in 2262 patients","volume":"272","author":"Ringden","year":"2012","journal-title":"Journal of Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD010189.pub3-BIB0091|cit91","first-page":"643","article-title":"Filgrastim-mobilized peripheral blood progenitor cells versus bone marrow transplantation for treating leukemia: 3-year results from the EBMT randomized trial","volume":"90","author":"Schmitz","year":"2005","journal-title":"Haematologica"},{"key":"10.1002\/14651858.CD010189.pub3-BIB0092|cit92","unstructured":"Sch\u00fcnemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing 'Summary of findings' tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook\/archive\/v6.3"},{"issue":"1","key":"10.1002\/14651858.CD010189.pub3-BIB0093|cit93","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006406.pub2","article-title":"Bone marrow harvest versus peripheral stem cell collection for haemopoietic stem cell donation in healthy donors","author":"Siddiq","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD010189.pub3-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jclinepi.2019.10.015","article-title":"GRADE guidelines 27: how to calculate absolute effects for time-to-event outcomes in summary of findings tables and Evidence Profiles","volume":"118","author":"Skoetz","year":"2020","journal-title":"Journal of Clinical Epidemiology"},{"issue":"17","key":"10.1002\/14651858.CD010189.pub3-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1001\/jama.2011.1558","article-title":"Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies","volume":"306","author":"Sorror","year":"2011","journal-title":"Journal of the American Medical Association"},{"issue":"22","key":"10.1002\/14651858.CD010189.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.1200\/JCO.2005.09.020","article-title":"Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematological malignancies: an individual patient data meta-analysis of nine randomised trials","volume":"23","author":"Stem Cell Trialists' Collaborative Group","year":"2005","journal-title":"Journal of Clinical Oncology"},{"issue":"6","key":"10.1002\/14651858.CD010189.pub3-BIB0097|cit97","first-page":"539","article-title":"Individual patient data meta-analysis of allogeneic peripheral blood stem cell transplant versus bone marrow transplant in the management of hematological malignancies: indirect assessment of the effect of the day 11 methotrexate administration","volume":"38","author":"Stem Cell Trialists' Collaborative Group","year":"2006","journal-title":"Bone Marrow Transplantation"},{"key":"10.1002\/14651858.CD010189.pub3-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"issue":"3","key":"10.1002\/14651858.CD010189.pub3-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1182\/blood-2009-03-208983","article-title":"Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD","volume":"114","author":"Vigorito","year":"2009","journal-title":"Blood"},{"issue":"2","key":"10.1002\/14651858.CD010189.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.bbmt.2015.09.013","article-title":"Infections after transplantation of bone marrow or peripheral blood stem cells from unrelated donors","volume":"22","author":"Young","year":"2016","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1002\/14651858.CD010189.pub3-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.critrevonc.2018.05.017","article-title":"Bone marrow versus peripheral blood as a graft source for haploidentical donor transplantation in adults using post-transplant cyclophosphamide-A systematic review and meta-analysis","volume":"133","author":"Yu","year":"2019","journal-title":"Critical Reviews in Oncology\/Hematology"},{"issue":"22","key":"10.1002\/14651858.CD010189.pub3-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMra1609337","article-title":"Acute graft-versus-host disease - biologic process, prevention, and therapy","volume":"377","author":"Zeiser","year":"2017","journal-title":"New England Journal of Medicine"},{"issue":"26","key":"10.1002\/14651858.CD010189.pub3-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1056\/NEJMra1703472","article-title":"Pathophysiology of chronic graft-versus-host disease and therapeutic targets","volume":"377","author":"Zeiser","year":"2017","journal-title":"New England Journal of Medicine"},{"issue":"11","key":"10.1002\/14651858.CD010189.pub3-BIB0104|cit104","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010189","article-title":"Bone marrow versus peripheral blood allogeneic hematopoietic stem cell transplantation for haematological malignancies","author":"Holtick","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD010189.pub3-BIB0105|cit105","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010189.pub2","article-title":"Comparison of bone marrow versus peripheral blood allogeneic hematopoietic stem cell transplantation for hematological malignancies in adults - a systematic review and meta-analysis","author":"Holtick","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:06:22Z","timestamp":1788739582000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010189.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,11,7]]},"references-count":105,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010189.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,7]]}}}